info icon

Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers)

C3_LIVER_INTRAHEPATIC3_BILE_DUCTS_EXALLC

No definition available.

Endpoint definition

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule None

diagram downward connector

Check conditions None

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Cancer registry: Topography ICD-O-3 C22
Cancer registry: Morphology ICD-O-3 ANY
Cancer registry: Behaviour codes ANY

1 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

662

diagram downward connector
C3_LIVER_INTRAHEPATIC3_BILE_DUCTS_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers) based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 662 118 544
Unadjusted prevalence (%) 0.18 0.06 0.33
Mean age at first event (years) 70.89 68.29 71.46

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: C3_LIVER_INTRAHEPATIC3_BILE_DUCTS_EXALLC – Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers)
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Malignant neoplasm of liver and intrahepatic bile ducts (controls excluding all cancers)

Endpoint not on priority list, no data to show.